Our Business Model
Medefil is growing as a fully integrated specialty pharmaceutical company. At Medefil our goal is to develop and manufacture injectable products where quality and supply reliability are crucial, and safety and ease-of-use are of utmost importance.
We are focused on establishing an organization with comprehensive infrastructure for injectable product development, state-of-the-art manufacturing capabilities and a streamlined process for execution that will help address critical issues and unmet needs in the pharmaceutical injectable space.
Critical Injectables
Injectable products with shortage and supply issues
Complex Injectables
Difficult to develop and manufacture injectable products
Product Enhancement
Enhancement of injectable products to create value at the point of care
Our Pipeline
Critical Injectables
Therapeutic Area | FDA Filing | Delivery Technology | History of Shortage |
---|---|---|---|
Critical Care | ANDA | Syringe | Yes |
Critical Care | ANDA | Vial | Yes |
Pain | ANDA | Vial | No |
Anti-Infective | ANDA | Vial | No |
Critical Care | ANDA | Syringe | No |
Anti-Injective | ANDA | Lyo | No |
Critical Care | NDA | Vial | Yes |
Critical Care | ANDA | Vial | Yes |
Critical Care | ANDA | Vial | Yes |
Critical Care | ANDA | Vial | Yes |
Critical Care | ANDA | Vial | Yes |
Critical Care | ANDA | Vial | Yes |
Complex Injectables
Therapeutic Area | FDA Filing | Delivery Technology |
---|---|---|
Pain | ANDA | Premix Bag |
Critical Care | ANDA | Suspension |
Anti-Infective | ANDA | Premix Bag |
Critical Care | ANDA | Suspension |